Histopathology and cytopathology of cervical cancer.
Jenkins
David
D
Glaxo Smith Kline Biologicals, Rixensart, Belgium, University of Nottingham, Nottingham, UK. David.D.Jenkins@gskbio.com
D000230:Adenocarcinoma / Q000209:etiology / Q000473:pathology / Q000821:virology; D002294:Carcinoma, Squamous Cell / Q000473:pathology; D003951:Diagnostic Errors; D005260:Female; D006801:Humans; D008403:Mass Screening; D008954:Models, Biological; D027383:Papillomaviridae / Q000145:classification / Q000235:genetics / Q000472:pathogenicity; D030361:Papillomavirus Infections / Q000150:complications / Q000473:pathology / Q000821:virology; D011230:Precancerous Conditions / Q000209:etiology / Q000473:pathology / Q000821:virology; D012680:Sensitivity and Specificity; D002583:Uterine Cervical Neoplasms / Q000209:etiology / Q000473:pathology* / Q000821:virology; D014626:Vaginal Smears / Q000706:statistics & numerical data; D002578:Uterine Cervical Dysplasia / Q000209:etiology / Q000473:pathology / Q000821:virology